Company intelligence / Profile preview
CSL Behring
King of Prussia, Pennsylvania, United Statescsl.com ↗
- Ownership
- Public · CSL
- Employees
- ~27000
- Development stage
- Commercial
01
Overview
CSL Behring offers a broad range of quality plasma-derived and recombinant therapies for rare and serious diseases. Their products include treatments for coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders.
- Therapeutic areas
- PulmonologyCardiovascularImmunologyHematologyRare DiseasesNeurology
- Modalities
- Plasma-derived therapiesRecombinant protein technologyCell and gene therapy
- Industry
- Pharma
02
Drug pipeline
55 assets54 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on CSL Behring.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CSL Behring.